Memorial Sloan Kettering Cancer Center: Carcinoma trials

The registry lists 34 Carcinoma studies with Memorial Sloan Kettering Cancer Center as lead sponsor. 0 are open to participants now and 16 have results posted.

Early Phase 1 1Phase 1 7Phase 2 17No phase 11(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Talazoparib and Avelumab in Participants With Metastatic Renal Cell CarcinomaCompletedNCT04068831Phase 2Results posted
• Evaluating Immune Therapy, Durvalumab (MEDI4736) With Tremelimumab for Metastatic, Non-transitional Cell Carcinoma of the Urinary TractCompletedNCT03430895Phase 2Results posted
• A Study of Durvalumab With or Without Tremelimumab in Endometrial CancerCompletedNCT03015129Phase 2Results posted
• A Study of T-VEC (Talimogene Laherparepvec) With or Without Radiotherapy for Melanoma, Merkel Cell Carcinoma, or Other Solid TumorsCompletedNCT02819843Phase 2Results posted
• Screening Trial of Nivolumab With Image Guided, Stereotactic Body Radiotherapy (SBRT) Versus Nivolumab Alone in Patients With Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)CompletedNCT02684253Phase 2Results posted
• First Line Gemcitabine, Cisplatin and MEK162 in Advanced Biliary Tract CarcinomaCompletedNCT01828034Phase 1/2Results posted
• Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)CompletedNCT01642186Phase 2Results posted
• Axitinib (AG-013736) in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic CarcinomaCompletedNCT01558661Phase 2Results posted
• Buparlisib in Metastatic Transitional Cell Carcinoma of the UrotheliumCompletedNCT01551030Phase 2Results posted
• BEZ235 in Patients With Advanced Renal Cell Carcinoma (RCC)TerminatedNCT01453595Phase 1/2Results posted
• Everolimus and Bevacizumab in Advanced Non-Clear Cell Renal Cell Carcinoma (RCC)CompletedNCT01399918Phase 2Results posted
• Pharmacodynamic Effects of Ribavirin in Patients With Tonsil and/or Base of Tongue Squamous Cell CarcinomaCompletedNCT01268579Not applicableResults posted
• Everolimus (RAD001) in Metastatic Transitional Cell Carcinoma of the UrotheliumCompletedNCT00805129Phase 2Results posted
• Phase II Trial of Preoperative Combined Modality Therapy for Esophageal Carcinoma: Cisplatin-Irinotecan Followed by Radiation Therapy With Concurrent Cisplatin and Irinotecan.CompletedNCT00590031Phase 2Results posted
• Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metastatic Urothelial CarcinomaCompletedNCT00588666Phase 2Results posted
• Trial of Beads Versus Doxorubicin Eluting Beads for Arterial Embolization of Hepatocellular CarcinomaCompletedNCT00539643Phase 2Results posted
• A Study of 1 8F-FDHT PET/MRIScans in Women With Breast CancerWithdrawnNCT06145399Early Phase 1
• Testing Lenvatinib and Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma and Cutaneous Squamous Cell CarcinomaCompletedNCT03524326Phase 1
• Exercise Exposure Data Collection in Patients Undergoing Tumor Molecular ProfilingActive, not recruitingNCT03208374
• Study of Enzalutamide With and Without Sorafenib in Advanced Hepatocellular Carcinoma PatientsCompletedNCT02642913Phase 1
• Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Gemcitabine as Adjuvant Treatment After Resection of Intrahepatic CholangiocarcinomaCompletedNCT01938729Phase 1
• Reflectance Confocal Microscopy of Wounds During Moh's Surgery: Feasibility Testing of a Mosaicing Algorithm for Intraoperative Imaging of Cancer MarginsCompletedNCT01872130
• Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally InvasiveCompletedNCT01262040Not applicable
• Proximal Molecular Effects of Concurrent Chemoradiotherapy on Head and Neck Squamous Cell CarcinomaCompletedNCT00620139
• Confocal Reflectance Microscopy of Shave-Biopsy Sites on Skin in Vivo.CompletedNCT00601185
• Molecular Effects of Short-Term Celecoxib Treatment on Head and Neck Squamous Cell CarcinomaCompletedNCT00596219Not applicable
• Intra-Operative Lymphatic Mapping in Patients With Invasive Carcinoma of the Cervix or Endometrial CarcinomaCompletedNCT00595725Not applicable
• Improving Therapeutic Outcomes in the Tongue Carcinoma Patient: Assessment of Adaptation Using Functional Magnetic Resonance Imaging and Diffusion Tensor ImagingCompletedNCT00594724Not applicable
• Molecular Genetic Basis of Invasive Breast Cancer Risk Associated With Lobular Carcinoma in SituCompletedNCT00581750
• Multi-Wavelength and Coherence Confocal Reflectance Microscopy of Pigmented and Non-Pigmented Lesions on the Skin In-VivoCompletedNCT00574392
• A Study of RAD001 and Sunitinib in Metastatic Renal Cell CarcinomaCompletedNCT00422344Phase 1
• A Phase I Study of Bevacizumab and Sunitinib in Metastatic Renal Cell Carcinoma PatientsCompletedNCT00421512Phase 1
• SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and NeckCompletedNCT00006361Phase 2
• Irinotecan in Treating Patients With Advanced Neuroendocrine TumorsCompletedNCT00004922Phase 2